Software and Pharma, moving beyond drug discovery
TL:DR - Is there a real opportunity for digital health companies to do more with pharma? Yes, but….
Read more →The Dougri newsletter, the Differential Diagnosis blog, portfolio news, firm news and events, all in one place.
TL:DR - Is there a real opportunity for digital health companies to do more with pharma? Yes, but….
Read more →
Or - Why now it might be a good time to stress test your GTM hypothesis?
Read more →
Jeff Bezos, Tim Cook, Mark Zuckerberg, Sundar Pichai and Satya Nadella were just heading off the back room of the small restaurant. Nothing but smiles and hugs were seen.
Read more →
Much has been said about the huge potential Israel has as a digital health powerhouse. One of the most common arguments is the breadth and depth of data available for research and…
Read more →
Or the customer segment that can’t be ignored any more
Read more →
In the last couple of weeks there has been on a lot of chatter on the gloomy situation of telehealth companies. Teladoc’s stock is down >70% from its peak in Jan 21…
Read more →
A tale of selling drugs with software margins
Read more →
Opportunities around value based care and the Israeli angle
Read more →
Is it just me or no matter where you turn your head it seems like Value based care (VBC) is expected to be this magic wand that will reduce healthcare (unnecessary) costs…
Read more →
Decision support systems (DSS) and AI-based prediction / improvement tools have been presented in the past years as one of the biggest hopes to remedy an inefficient, burnt-out health system. To some…
Read more →Insights from the A2 team, straight to your inbox. Unsubscribe anytime.